General Atlantic — Unmapped CUSIP

How General Atlantic's position in Seaport Therapeutics changed quarter by quarter. Change badges compare each quarter to the fund's immediately-prior filing. CUSIP 81221K108 needs mapping

Quarters held

1

First reported

Q2 2026

Latest value

$132,526,361

Latest weight

4.6%

Peak weight

4.6%

Shares since first

0%

Position Trend

Shares, value, and weight from first report to latest report.

General Atlantic first reported 6,101,582 shares in Q2 2026 and most recently reported 6,101,582 shares in Q2 2026. Portfolio weight peaked at 4.6% in Q2 2026; the low reported weight was 4.6% in Q2 2026.

Since the first report, shares are 0% and reported value is 0%. Latest move: NEW